TRVN Trevena

Watchlist

1.280
0.0000.00%

15min DelayClose Mar 21 15:49 ET

1.11MMarket Cap-0.03P/E (TTM)

About Trevena Company

Trevena, Inc. is a biopharmaceutical company, which focuses on developing and commercializing novel medicines for patients affected by central nervous system, or CNS, disorders. Its product candidates include Oliceridine injection, TRV250, TRV734, and TRV045. The company was founded by Maxine Gowen, Robert Joseph Lefkowitz, Scott DeWire, Howard A. Rockman, Jonathan Violin, and Erin Whalen on November 9, 2007 and is headquartered in Chesterbrook, PA.

Company Profile

SymbolTRVN

Company NameTrevena

Listing DateJan 31, 2014

Issue Price7.00

Founded2007

CEOMs. Carrie L. Bourdow

MarketPink Market

Employees23

Fiscal Year Ends12-31

Address955 Chesterbrook Boulevard,Suite 110

CityChesterbrook

ProvincePennsylvania

CountryUnited States of America

Zip Code19087

Phone1-610-354-8840

Websitehttp://www.trevena.com

Company Executives

Name
Position
Salary

Carrie L. Bourdow
Chairman of the Board, President and Chief Executive Officer
1.66M

Barry Shin
Executive Vice President, Chief Operating Officer, Chief Financial Officer and Principal Accounting Officer
1.01M

Robert T. Yoder
Senior Vice President, Chief Business Officer and Head, Commercial Operations
--

Dr. Mark A. Demitrack, M.D.
Senior Vice President and Chief Medical Officer
1.03M

Patricia M. Drake
Senior Vice President and Chief Commercial Officer
--

Jake R. Nunn
Independent Director
76.11K

Dr. Anne M. Phillips, M.D.
Independent Director
76.11K

Marvin H. Johnson, Jr
Independent Director
61.11K

Dr. Mark H.N. Corrigan, M.D.
Independent Director
55.87K

Dr. Scott Braunstein, M.D.
Lead Independent Director
70.11K

Barbara Yanni
Independent Director
76.58K

TRVN Trevena

About Trevena Company

Company Profile

Company Executives

Market Insights